KELLEY KARLET: Open Payments
NPI 1972957330 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,486 in 69 payments from 16 companies in 2025. Trend: 2023 $604 · 2024 $660 · 2025 $1,486
Food & beverage: $1,386Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $458 |
| GlaxoSmithKline, LLC. | 15 | $191 |
| Verona Pharma, Inc. | 10 | $189 |
| Regeneron Healthcare Solutions, Inc. | 7 | $136 |
| Electromed, Inc. | 5 | $108 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| HARMONY BIOSCIENCES LLC | 4 | $84 |
| JAZZ PHARMACEUTICALS INC. | 2 | $46 |
| GENZYME CORPORATION | 3 | $45 |
| Axsome Therapeutics, Inc. | 1 | $25 |
Products named: BREZTRI, DUPIXENT, Ohtuvayre, NUCALA, SMARTVEST, FASENRA, WAKIX, TRELEGY ELLIPTA.
Industry payments across WV — which companies pay providers there.
